Literature DB >> 3641479

HLA and narcolepsy in a German population.

G Mueller-Eckhardt, K Meier-Ewert, D J Schendel, F B Reinecker, G Multhoff, C Mueller-Eckhardt.   

Abstract

In this paper the first MHC data including HLA-A, B, C, DR, DQ and complement BF, C4A, C4B determinants in German narcoleptics are presented together with the first family studies in European Caucasoids. 57 out of 58 unrelated patients (98.3%) were positive for DR2 and DQw1, respectively. In contrast to all other reports, one patient with typical signs of narcolepsy was found to be DR2/DQw1 negative. Data showing significant increase in the frequency of B7, and normal frequencies of B35 were discordant with data from Japanese patients. Definition of the extended DR2 linked haplotypes, deduced from 6 families, revealed that 5 out of 12 were DQw1, DR2, BFS, C4B1, C4A3, B7 (Cw7), while 11/12 had DR2, DQw1, BFS, C4A3, C4B1 in common. In one multiple case family two genotypically different DR2 haplotypes were identified in affected siblings. Results from the family study were concordant with a dominant mode of inheritance with incomplete penetrance of a hypothetical disease susceptibility gene.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3641479     DOI: 10.1111/j.1399-0039.1986.tb00476.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

1.  The narcolepsy-associated DRw15,DQw6,Dw2 haplotype has no unique HLA-DQA or -DQB restriction fragments and does not extend to the HLA-DP subregion.

Authors:  O Olerup; M Schaffer; J Hillert; C Sachs
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

2.  Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity.

Authors:  Mehdi Tafti; Gert J Lammers; Yves Dauvilliers; Sebastiaan Overeem; Geert Mayer; Jacek Nowak; Corinne Pfister; Valérie Dubois; Jean-François Eliaou; Hans-Peter Eberhard; Roland Liblau; Aleksandra Wierzbicka; Peter Geisler; Claudio L Bassetti; Johannes Mathis; Michel Lecendreux; Ramin Khatami; Raphaël Heinzer; José Haba-Rubio; Eva Feketeova; Christian R Baumann; Zoltán Kutalik; Jean-Marie Tiercy
Journal:  Sleep       Date:  2016-03-01       Impact factor: 5.849

3.  Taq I-generated HLA-DQ alpha polymorphism in Japanese patients with narcolepsy.

Authors:  K Matsuki; H Maeda; T Juji; H Inoko; A Ando; K Tsuji; Y Honda
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

4.  HLA haplotypes, polysomnography, and pedigrees in a case series of patients with narcolepsy.

Authors:  R Hayduk; P Flodman; M A Spence; M K Erman; M M Mitler
Journal:  Sleep       Date:  1997-10       Impact factor: 5.849

Review 5.  Genetic factors in sleep disorders.

Authors:  J D Parkes; C B Lock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

Review 6.  Clinical and neurobiological aspects of narcolepsy.

Authors:  Seiji Nishino
Journal:  Sleep Med       Date:  2007-04-30       Impact factor: 3.492

Review 7.  Benefits and risks of pharmacotherapy for narcolepsy.

Authors:  Merrill M Mitler; Roza Hayduk
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 8.  History of narcolepsy at Stanford University.

Authors:  Emmanuel J M Mignot
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.